Welcome to the official Revivocell page.
Revivocell develops novel cell culture technology for the growth of cells in-vitro that better replicate the function of body like conditions. This includes multiple organ co-culture technology, non-destructive and more informative analysis techniques, and other platforms that gives scientists better tools for research.
We are passionate about providing scientists with innovative technology that enhances life sciences research to improve human health. In particular, our aim is to bring forward innovations that enable better prediction of body response to new drugs early in the pre-clinical stage and such increasing the success rate of developing better drugs as well as reduce the reliance on animal testing.
-
Industry
-
Biotechnology Research
-
Company size
-
2-10 employees
-
Headquarters
-
Daresbury, England
-
Type
-
Privately Held
-
Founded
-
2015
-
Specialties
-
Cell Culture technology, 3D cell culture, Predictive Toxicology, body-on-a-chip, and systems biology